ONGLYZA - 0003-4214-21 - (SAXAGLIPTIN)

Alphabetical Index


Drug Information of ONGLYZA

Product NDC: 0003-4214
Proprietary Name: ONGLYZA
Non Proprietary Name: SAXAGLIPTIN
Active Ingredient(s): 2.5    mg/1 & nbsp;   SAXAGLIPTIN
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of ONGLYZA

Product NDC: 0003-4214
Labeler Name: E.R. Squibb & Sons, L.L.C.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022350
Marketing Category: NDA
Start Marketing Date: 20090731

Package Information of ONGLYZA

Package NDC: 0003-4214-21
Package Description: 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-4214-21)

NDC Information of ONGLYZA

NDC Code 0003-4214-21
Proprietary Name ONGLYZA
Package Description 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-4214-21)
Product NDC 0003-4214
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name SAXAGLIPTIN
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20090731
Marketing Category Name NDA
Labeler Name E.R. Squibb & Sons, L.L.C.
Substance Name SAXAGLIPTIN HYDROCHLORIDE
Strength Number 2.5
Strength Unit mg/1
Pharmaceutical Classes Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA]

Complete Information of ONGLYZA


General Information